Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19. Livingstone R, Lin H, Brendish NJ, Poole S, et al. J Infect 2022 Jan 30. pii: S0163-4453(22)00049.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Livingstone R, Lin H, Brendish NJ, Poole S, et al. Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19. J Infect 2022 Jan 30. pii: S0163-4453(22)00049.
PMID: 35108599